Literature DB >> 22795500

Focal therapy of prostate cancer: energies and procedures.

G Bozzini1, P Colin, P Nevoux, A Villers, S Mordon, N Betrouni.   

Abstract

PURPOSE: Over the last years, focal therapy has emerged as an intermediate management technique between radical approaches (radical prostatectomy, external beam radiation, and brachytherapy) and watchful waiting to manage some early stage prostate cancers (CaP). Different energy modalities are being developed. The aim of this study is to review these energy modalities and their indications.
MATERIALS AND METHODS: We reviewed the literature to concentrate on the practical aspects of focal therapy for CaP with the following key words: photodynamic therapy, high intensity focused ultrasound (HIFU), cryotherapy, focal laser ablation, electroporation, radio frequency, external beam radiation, organ-sparing approach, focal therapy, CaP, and then by cross-referencing from previously identified studies.
RESULTS: Prostatic tumor ablation can be achieved with different energies: freezing effect for cryotherapy, thermal effect using focalized ultrasound for HIFU, and using thermal effect of light for focal laser ablation (FLA) and activation of a photosensitizer by light for PDT, among others. Radio frequency and microwave therapy have been tested in this field and demonstrated their usefulness. Electroporation is currently being developed on preclinical models. External beam radiation with microboost on neoplastic foci is under evaluation. HIFU and cryotherapy require the use of sophisticated and expensive machines and, consequently, the procedure is expensive. Laser techniques seem to be less onerous, with the added advantage of size.
CONCLUSIONS: Several energy modalities are being developed to achieve the trifecta of continence, potency, and oncologic efficiency. Those techniques come with low morbidity but clinical experience is limited regarding to oncologic outcome. Comparison of the different focal approaches is complex owing to important heterogeneity of the trials. In the future, it seems likely that each technique will have its own selective indications.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22795500     DOI: 10.1016/j.urolonc.2012.05.011

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  18 in total

Review 1.  Image-guided robotic interventions for prostate cancer.

Authors:  Ashwin N Sridhar; Archie Hughes-Hallett; Erik K Mayer; Philip J Pratt; Philip J Edwards; Guang-Zhong Yang; Ara W Darzi; Justin A Vale
Journal:  Nat Rev Urol       Date:  2013-06-18       Impact factor: 14.432

Review 2.  Prostate MR Imaging for Posttreatment Evaluation and Recurrence.

Authors:  Sonia Gaur; Baris Turkbey
Journal:  Radiol Clin North Am       Date:  2017-11-27       Impact factor: 2.303

3.  Temporal changes in MRI appearance of the prostate after focal ablation.

Authors:  Andreas M Hötker; Andreas Meier; Yousef Mazaheri; Junting Zheng; Marinela Capanu; Joshua Chaim; Ramon Sosa; Jonathan Coleman; Hedvig Hricak; Oguz Akin
Journal:  Abdom Radiol (NY)       Date:  2019-01

4.  Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.

Authors:  Andrew B Rosenkrantz; Michael J Triolo; Jonathan Melamed; Henry Rusinek; Samir S Taneja; Fang-Ming Deng
Journal:  J Magn Reson Imaging       Date:  2014-02-25       Impact factor: 4.813

Review 5.  Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insight.

Authors:  Andrzej M Bugaj
Journal:  World J Methodol       Date:  2016-03-26

6.  Nanotechnology for cancer treatment.

Authors:  William H Gmeiner; Supratim Ghosh
Journal:  Nanotechnol Rev       Date:  2015-04       Impact factor: 7.848

7.  Vascular targeted photodynamic therapy with TOOKAD® Soluble (WST11) in localized prostate cancer: efficiency of automatic pre-treatment planning.

Authors:  N Betrouni; S Boukris; F Benzaghou
Journal:  Lasers Med Sci       Date:  2017-06-01       Impact factor: 3.161

Review 8.  Mechanisms of cryoablation: clinical consequences on malignant tumors.

Authors:  J G Baust; A A Gage; T E Bjerklund Johansen; J M Baust
Journal:  Cryobiology       Date:  2013-11-13       Impact factor: 2.487

9.  Role of multiparametric MRI in long-term surveillance following focal laser ablation of prostate cancer.

Authors:  Mark Paxton; Eitan Barbalat; Nathan Perlis; Ravi J Menezes; Mark Gertner; David Dragas; Masoom A Haider; Antonio Finelli; John Trachtenberg; Sangeet Ghai
Journal:  Br J Radiol       Date:  2021-07-29       Impact factor: 3.039

Review 10.  Future prospects in the diagnosis and management of localized prostate cancer.

Authors:  Ahmet Tefekli; Murat Tunc
Journal:  ScientificWorldJournal       Date:  2013-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.